FARALLON CAPITAL MANAGEMENT LLC Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$18.0T
Holdings
228
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (228 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | RCREADY CAPITAL CORP | 1,250,226 | $16.8B | 0.09% | |
| 102 | 698ACHILLES THERAPEUTICS PLC | 1,000,000 | $16.6B | 0.09% | |
| 103 | —ZEALAND PHARMA A/S | 510,000 | $16.3B | 0.09% | |
| 104 | NVAX 3.75 02/01/23NOVAVAX INC | 10,000,000 | $16.1B | 0.09% | |
| 105 | RCELAVITA MEDICAL INC | 800,000 | $15.9B | 0.09% | |
| 106 | BEKEKE HLDGS INC | 273,000 | $15.6B | 0.09% | |
| 107 | RCKTROCKET PHARMACEUTICALS INC | 350,000 | $15.5B | 0.09% | |
| 108 | —AUSTERLITZ ACQUISITION CORP | 1,500,000 | $15.0B | 0.08% | |
| 109 | —KKR ACQUISITION HOLDING I CO | 1,500,000 | $15.0B | 0.08% | |
| 110 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 1,500,000 | $14.8B | 0.08% | |
| 111 | —DISRUPTIVE ACQUISITION CORP | 1,400,000 | $13.8B | 0.08% | |
| 112 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 300,000 | $13.5B | 0.07% | |
| 113 | —LONGBOARD PHARMACEUTICALS IN | 810,500 | $13.3B | 0.07% | |
| 114 | —NUANCE COMMUNICATIONS INC | 7,000,000 | $12.9B | 0.07% | |
| 115 | CMRXEURCHIMERIX INC | 1,300,000 | $12.5B | 0.07% | |
| 116 | —FOREST ROAD ACQUISITION COR | 1,250,000 | $12.4B | 0.07% | |
| 117 | GRFSGRIFOLS S A | 702,110 | $12.1B | 0.07% | |
| 118 | INBXUSDINHIBRX INC | 600,000 | $12.0B | 0.07% | |
| 119 | —AGILE GROWTH CORP | 1,200,000 | $11.9B | 0.07% | |
| 120 | DRIOEURDARIOHEALTH CORP | 600,000 | $11.6B | 0.06% | |
| 121 | ARWRARROWHEAD PHARMACEUTICALS IN | 172,454 | $11.4B | 0.06% | |
| 122 | —CURIS INC | 1,000,000 | $11.3B | 0.06% | |
| 123 | KURAKURA ONCOLOGY INC | 400,000 | $11.3B | 0.06% | |
| 124 | NGMUSDNGM BIOPHARMACEUTICALS INC | 375,000 | $10.9B | 0.06% | |
| 125 | —TIGA ACQUISITION CORP | 1,080,000 | $10.8B | 0.06% | |
| 126 | DMTKQDERMTECH INC | 200,000 | $10.2B | 0.06% | |
| 127 | QUREUNIQURE NV | 300,000 | $10.1B | 0.06% | |
| 128 | —PLURALSIGHT INC | 450,000 | $10.1B | 0.06% | |
| 129 | —ROCKET INTERNET GRWT OPRT CO | 1,000,000 | $10.0B | 0.06% | |
| 130 | —ARES ACQUISITION CORPORATION | 1,000,000 | $10.0B | 0.06% | |
| 131 | CCIXCHURCHILL CAPITAL CORP VII | 1,000,000 | $10.0B | 0.06% | |
| 132 | —FS DEVELOPMENT CORP II | 1,000,000 | $10.0B | 0.06% | |
| 133 | —CORAZON CAPITAL V838 MONOCER | 1,000,000 | $9.9B | 0.06% | |
| 134 | —VIRGIN GROUP ACQUISIT CORP I | 1,000,000 | $9.9B | 0.06% | |
| 135 | —FORUM MERGER IV CORP | 1,000,000 | $9.9B | 0.05% | |
| 136 | —TAILWIND TWO ACQUISITION COR | 1,000,000 | $9.9B | 0.05% | |
| 137 | —CASCADE ACQUISITION CORP | 990,000 | $9.7B | 0.05% | |
| 138 | —AVROBIO INC | 740,000 | $9.4B | 0.05% | |
| 139 | GOSS 5 06/01/27GOSSAMER BIO INC | 10,000,000 | $8.9B | 0.05% | |
| 140 | BDQMALBIREO PHARMA INC | 250,000 | $8.8B | 0.05% | |
| 141 | YB4PSAVARA INC | 4,125,877 | $8.6B | 0.05% | |
| 142 | —ARYA SCIENCES ACQU CORP IV | 800,000 | $8.3B | 0.05% | |
| 143 | BOLT1EURBOLT BIOTRAPEUTICS INC | 250,000 | $8.2B | 0.05% | |
| 144 | JWSMFJAWS MUSTANG ACQUISITION COR | 800,000 | $8.1B | 0.05% | |
| 145 | —LEVERE HOLDINGS CORP | 800,000 | $8.0B | 0.04% | |
| 146 | SURFUSDSURFACE ONCOLOGY INC | 1,000,000 | $7.8B | 0.04% | |
| 147 | —KINNATE BIOPHARMA INC | 250,000 | $7.8B | 0.04% | |
| 148 | —RESEARCH ALLIANCE CORP II | 750,000 | $7.7B | 0.04% | |
| 149 | —GORES METROPOULOS II INC | 750,000 | $7.6B | 0.04% | |
| 150 | —WARBURG PINCUS CAPTAL CORP I | 750,000 | $7.6B | 0.04% | |
| 151 | —REINVENT TECHNOLOGY PARTNERS | 750,000 | $7.5B | 0.04% | |
| 152 | —ARCLIGHT CLEAN TRANSITION II | 750,000 | $7.5B | 0.04% | |
| 153 | —APOLLO STRATEGIC GRWT CPTL I | 750,000 | $7.5B | 0.04% | |
| 154 | —WARBURG PINCUS CAPTAL CORP I | 750,000 | $7.5B | 0.04% | |
| 155 | —GORES HOLDINGS VII INC | 750,000 | $7.5B | 0.04% | |
| 156 | —SOCIAL LEVERAGE ACQUISN CORP | 750,000 | $7.5B | 0.04% | |
| 157 | —PATHFINDER ACQUISITION CORP | 750,000 | $7.4B | 0.04% | |
| 158 | —VECTOR ACQUISITION CORP II | 750,000 | $7.4B | 0.04% | |
| 159 | —THUNDER BRIDGE CAP PRTNRS II | 750,000 | $7.4B | 0.04% | |
| 160 | CNTBCONNECT BIOPHARMA HLDGS LTD | 400,000 | $7.4B | 0.04% | |
| 161 | —NOVUS CAPITAL CORPORATION II | 700,000 | $7.0B | 0.04% | |
| 162 | —SUPERNOVA PARTN ACQ CO III L | 700,000 | $7.0B | 0.04% | |
| 163 | —RADIUS HEALTH INC | 6,783,000 | $6.4B | 0.04% | |
| 164 | —FINCH THERAPEUTICS GROUP INC | 390,000 | $6.2B | 0.03% | |
| 165 | IMGNEURIMMUNOGEN INC | 750,000 | $6.1B | 0.03% | |
| 166 | —KHOSLA VENTURES ACQUISITION | 600,000 | $6.1B | 0.03% | |
| 167 | —GORES TECHNOLOGY PARTNERS II | 600,000 | $6.0B | 0.03% | |
| 168 | —FINSERV ACQUISITION CORP II | 600,000 | $6.0B | 0.03% | |
| 169 | —INTERPRIVATE IV INFRATECH PR | 600,000 | $5.9B | 0.03% | |
| 170 | —RXR ACQUISITION CORP | 600,000 | $5.9B | 0.03% | |
| 171 | PHVSPHARVARIS N V | 200,000 | $5.6B | 0.03% | |
| 172 | COGTUNUM THERAPEUTICS INC | 600,000 | $5.3B | 0.03% | |
| 173 | —HARPOON THERAPEUTICS INC | 250,000 | $5.2B | 0.03% | |
| 174 | —THOMA BRAVO ADVANTAGE | 500,000 | $5.2B | 0.03% | |
| 175 | CGEMCULLINAN ONCOLOGY INC | 125,000 | $5.2B | 0.03% | |
| 176 | INNVINNOVAGE HLDG CORP | 200,000 | $5.2B | 0.03% | |
| 177 | —SOARING EAGLE ACQUISITION CO | 500,000 | $5.1B | 0.03% | |
| 178 | —AUSTERLITZ ACQUISITION CORP | 500,000 | $5.0B | 0.03% | |
| 179 | —G SQUARED ASCEND I INC | 500,000 | $5.0B | 0.03% | |
| 180 | —FIFTH WALL ACQUISITION CORP | 500,000 | $5.0B | 0.03% | |
| 181 | —FTAC HERA ACQUISITION CORP | 500,000 | $5.0B | 0.03% | |
| 182 | —LANDCADIA HOLDINGS IV INC | 500,000 | $5.0B | 0.03% | |
| 183 | —COLONNADE ACQUISITION CORP I | 500,000 | $4.9B | 0.03% | |
| 184 | APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC | 3,522,000 | $4.9B | 0.03% | |
| 185 | EQEQUILLIUM INC | 680,000 | $4.9B | 0.03% | |
| 186 | —SCION TECH GROWTH II | 450,000 | $4.5B | 0.02% | |
| 187 | —NIGHTDRAGON ACQUISITION CORP | 400,000 | $4.1B | 0.02% | |
| 188 | —HUMANCO ACQUISITION CORP | 408,900 | $4.1B | 0.02% | |
| 189 | CCIXCHURCHILL CAPITAL CORP VI | 400,000 | $4.0B | 0.02% | |
| 190 | —FIRST RESERVE SUSTAINABLE GW | 400,000 | $4.0B | 0.02% | |
| 191 | —GORES HLDGS VIII INC | 400,000 | $4.0B | 0.02% | |
| 192 | —INTERPRIVATE II ACQUISITION | 400,000 | $4.0B | 0.02% | |
| 193 | —AFFIMED N V | 500,000 | $4.0B | 0.02% | |
| 194 | —ALKURI GLOBAL ACQUISITION CO | 400,000 | $4.0B | 0.02% | |
| 195 | —VPC IMPACT ACQU HOLDI III IN | 400,000 | $3.9B | 0.02% | |
| 196 | —INTERPRIVATE III FINANCIAL P | 400,000 | $3.9B | 0.02% | |
| 197 | —CM LIFE SCIENCES II INC | 250,000 | $3.2B | 0.02% | |
| 198 | —LONGVIEW ACQUISITION CORP II | 304,698 | $3.1B | 0.02% | |
| 199 | —LAZARD GROWTH ACQUISITION CO | 300,000 | $3.0B | 0.02% | |
| 200 | SGFYGBPSIGNIFY HEALTH INC | 100,000 | $2.9B | 0.02% |